For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 15,234 | |||
| General and administrative | 7,887 | |||
| Total operating expenses | 23,121 | |||
| Loss from operations | -23,121 | |||
| Change in fair value of financial instruments | -6,000 | |||
| Interest expense | 1,422 | |||
| Interest income | 713 | |||
| Other income | 268 | |||
| Total other income (expense) | -6,441 | |||
| Net loss | -29,562 | |||
| Basic EPS | -1.97 | |||
| Diluted EPS | -1.97 | |||
| Basic Average Shares | 15,011,321 | |||
| Diluted Average Shares | 15,011,321 | |||
CalciMedica, Inc. (CALC)
CalciMedica, Inc. (CALC)